Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Rabeprazole to Reduce Upper GI Events in Patients on Antithrombotics
NCT04416581Phase 4Recruiting
- Sponsor
- Duk-Woo Park
- Start
- May 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegoprazan in gastrointestinal bleeding, Peptic ulcer disease (PUD), sponsored by Duk-Woo Park. Started May 2021; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
gastrointestinal bleedingPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT04416581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416581.